Literature DB >> 17353195

Sequence dependence and differential expression of Ggamma5 subunit isoforms of the heterotrimeric G proteins variably processed after prenylation in mammalian cells.

Eric L Kilpatrick1, John D Hildebrandt.   

Abstract

Between 1 and 2% of proteins coded for in the human genome, including all G protein gamma subunits, are predicted to be prenylated. Subsequently, prenylated proteins are proteolytically cleaved at the C terminus and carboxymethylated. These reactions are generally obligatory events required for functional expression of prenylated proteins. The biological role of prenyl substrates has made these reactions significant targets for anticancer drug development. Understanding the enzymology of this pathway will be key to success for this strategy. When Ggamma1, -2, -4, -10, -11, -12, and -13 were expressed in HEK293 cells they were completely processed according to the current understanding of the prenylation reaction. In contrast, Ggamma5 was processed to two forms; a minor one, fully processed as predicted, and a major one that was prenylated without further processing. When the Ca(1)a(2)X motif of Ggamma5, CSFL, was exchanged for that of Ggamma2, CAIL, Ggamma5 was completely processed. Conversely, Ggamma2-SFL was incompletely processed. Differential processing of Ggamma5 was found due to the presence of an aromatic amino acid in its Ca(1)a(2)X motif. Retrieving endogenous Ggamma subunits from HEK293 or Neuro-2a cells with FLAG-Gbeta constructs identified multiple Ggamma subunits by mass spectrometry in either cell, but in both cases the most prominent one was Ggamma5 expressed without C-terminal processing after prenylation. This work indicates that post-prenylation reactions can generate multiple products determined by the C-terminal Ca(1)a(2)X motif. Within the human genome 10% of predicted prenylated proteins have aromatic amino acids in their Ca(1)a(2)X sequence and would likely generate the prenylation pattern described here.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353195     DOI: 10.1074/jbc.M701338200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Structural determinants involved in the formation and activation of G protein betagamma dimers.

Authors:  William E McIntire
Journal:  Neurosignals       Date:  2009-02-12

2.  Binding of β4γ5 by adenosine A1 and A2A receptors determined by stable isotope labeling with amino acids in cell culture and mass spectrometry.

Authors:  Dora Bigler Wang; Nicholas E Sherman; John D Shannon; Susan A Leonhardt; Linnia H Mayeenuddin; Mark Yeager; William E McIntire
Journal:  Biochemistry       Date:  2010-12-17       Impact factor: 3.162

3.  Quantitative Multiple-Reaction Monitoring Proteomic Analysis of Gβ and Gγ Subunits in C57Bl6/J Brain Synaptosomes.

Authors:  Yun Young Yim; W Hayes McDonald; Karren Hyde; Osvaldo Cruz-Rodríguez; John J G Tesmer; Heidi E Hamm
Journal:  Biochemistry       Date:  2017-09-21       Impact factor: 3.162

4.  Efficient farnesylation of an extended C-terminal C(x)3X sequence motif expands the scope of the prenylated proteome.

Authors:  Melanie J Blanden; Kiall F Suazo; Emily R Hildebrandt; Daniel S Hardgrove; Meet Patel; William P Saunders; Mark D Distefano; Walter K Schmidt; James L Hougland
Journal:  J Biol Chem       Date:  2017-12-27       Impact factor: 5.157

5.  Diversity of heterotrimeric G-protein γ subunits in plants.

Authors:  Yuri Trusov; David Chakravorty; José Ramón Botella
Journal:  BMC Res Notes       Date:  2012-10-31

6.  Differential localization of G protein βγ subunits.

Authors:  Katherine M Betke; Kristie L Rose; David B Friedman; Anthony J Baucum; Karren Hyde; Kevin L Schey; Heidi E Hamm
Journal:  Biochemistry       Date:  2014-04-01       Impact factor: 3.162

7.  A shunt pathway limits the CaaX processing of Hsp40 Ydj1p and regulates Ydj1p-dependent phenotypes.

Authors:  Emily R Hildebrandt; Michael Cheng; Peng Zhao; June H Kim; Lance Wells; Walter K Schmidt
Journal:  Elife       Date:  2016-08-15       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.